Bristol oncology research
Executive Summary
Susan Arbuck, MD, joins Bristol-Myers Squibb Sept. 4 as VP-oncology clinical research. Arbuck formerly headed the National Cancer Institute's developmental chemotherapy section
You may also be interested in...
Schering oncology development VP
Schering-Plough's new VP-global clinical development-oncology is former Aventis VP-Oncology Susan Arbuck. Arbuck has also held the position of VP-oncology clinical research with Bristol-Myers Squibb and headed the National Cancer Institute's developmental chemotherapy section (1"The Pink Sheet" Sept. 10, 2001, p. 32)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011